56
2
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T11539 |
HCV-IN-29
|
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
HCV-IN-29 是一种丙型肝炎病毒抑制剂。 | |||
T11541 |
HCV-IN-30
|
Others; HCV Protease | Microbiology/Virology; Others; Proteases/Proteasome |
HCV-IN-30 是 HCV NS5A 复制复合物的抑制剂(基因型 1a 和 1b 复制子的 IC50 = 901 和 102 nM)。 | |||
T38237 |
2′-O-Methylcytidine
|
Nucleoside Antimetabolite/Analog; HCV Protease | Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Microbiology/Virology; Proteases/Proteasome |
2'-O-Methylcytidine 是 2'-代核苷,可抑制 HCV 复制。 它在体外抑制 NS5B 催化的 RNA 合成,其抑制方式是与底物核苷三磷酸竞争。 | |||
T9567 |
Samatasvir
ATOLIHZIXHZSBA-BTSKBWHGSA-N,IDX719 |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Samatasvir (ATOLIHZIXHZSBA-BTSKBWHGSA-N) 是 NS5A HCV 复制抑制剂。它能够有效的选择复制子及感染性 HCV,在基因型 1至5 复制子中,EC50= 2~24 pM。 | |||
T4686 |
Simeprevir
TMC435,西咪匹韦,TMC-435350,Olysio |
HCV Protease; SARS-CoV | Microbiology/Virology; Proteases/Proteasome |
Simeprevir (TMC435) 是一种有效的 HCV NS3/4A 蛋白酶抑制剂,抑制 HCV 复制,EC50 为 7.8 nM。它也是 SARS-CoV-2 3CLpro 抑制剂。 | |||
T11281L |
FGI-106 tetrahydrochloride
|
Virus Protease; HCV Protease; Influenza Virus; HIV Protease | Microbiology/Virology; Proteases/Proteasome |
FGI-106 tetrahydrochloride 对多种病毒具有抑制活性,有抗埃博拉病毒,裂谷病毒和登革热病毒的 EC50分别为 100 nM,800 nM 和 400-900 nM,抑制非失血性发热病毒HCV 和HIV-1的EC50分别为 200 nM 和 150 nM 。 | |||
TQ0162 |
R-1479
4'-Azidocytidine |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
R-1479 (4'-Azidocytidine) 是一种 RdRp 抑制剂,对于 HCV 亚基因组复制子系统中的 HCV RNA 复制,IC50 值为 1.28 μM。 | |||
T16088 |
MK-0608
|
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
MK-0608 是一种可口服的体外 HCV 复制抑制剂。在亚基因组复制子测定中,EC50值为 0.3 μM,EC90值为 1.3 μM。 | |||
T9331 |
Bemnifosbuvir hemisulfate
AT-527 |
HCV Protease; SARS-CoV | Microbiology/Virology; Proteases/Proteasome |
Bemnifosbuvir hemisulfate (AT-527) 是一种 HCV 病毒复制抑制剂。 | |||
T3489 |
Dasabuvir
ABT-333,达塞布韦 |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Dasabuvir (ABT-333) 是丙型肝炎病毒非结构蛋白 5B 的非核苷抑制剂,是一种 RNA 依赖性 RNA 聚合酶,具有抗 HCV 的潜在活性。 | |||
T16710 |
Mericitabine
R-7128,RG 7128,PSI 6130 diisobutyrate |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Mericitabine (R-7128) 是一种核苷HCV NS5B 聚合酶抑制剂。它充当 RNA 链终止子并防止 RNA 转录物在复制过程中延伸。 | |||
T1822L |
Clemizole hydrochloride
克立咪唑盐酸,盐酸克立咪唑 |
HCV Protease; Histamine Receptor | GPCR/G Protein; Immunology/Inflammation; Microbiology/Virology; Neuroscience; Proteases/Proteasome |
Clemizole hydrochloride 是一种 TRPC5通道的抑制剂。它还是一种 H1 组胺受体拮抗剂,抑制 HCV 复制。 | |||
T12961 |
Sofosbuvir impurity F
索非布韦杂质 F,Sofosbuvir 3',5'-Bis-(S)-phosphate |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Sofosbuvir impurity F (Sofosbuvir 3',5'-Bis-(S)-phosphate) 既是 Sofosbuvir 的非对映异构体,也是 Sofosbuvir 的杂质,Sofosbuvir 是 HCV RNA 复制的抑制剂。 | |||
T9249 |
ITMN4077
|
Antiviral | Immunology/Inflammation |
ITMN4077 对感染人类 HuH7 细胞的丙型肝炎病毒具有抗病毒活性,评估为抑制 HCV 亚基因组复制子复制,EC50 为 2.131μM。 | |||
T1822 |
Clemizole
克立咪唑,吡咯咪唑 |
HCV Protease; Histamine Receptor | GPCR/G Protein; Immunology/Inflammation; Microbiology/Virology; Neuroscience; Proteases/Proteasome |
Clemizole 是一种 H1 组胺受体拮抗剂,可抑制 NS4B 的 RNA 结合和丙型肝炎病毒复制。它也是TRP5通道抑制剂。 | |||
T3226 |
Paritaprevir
ABT-450,Veruprevir,帕利瑞韦 |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Paritaprevir (ABT-450) 是一种口服生物可利用的合成酰基磺酰胺抑制剂,可抑制丙型肝炎病毒 (HCV) 蛋白酶复合物,由非结构蛋白 3 和 4A (NS3/NS4A) 组成,对 HCV 基因型 1 具有潜在活性。 给药后,paritaprevir 可逆地结合 HCV NS3/NS4A 蛋白酶的活性中心和结合位点,并阻止 NS3/NS4A 蛋白酶介导的多蛋白成熟。这会破坏病毒蛋白的加工和病毒复制复合物的形成,从而抑制病毒在 HCV 基因型 1 感染的宿主细胞中的复制。 NS3 是一种丝氨酸蛋白酶,对于 HCV 多蛋白内多个位点的蛋白水解切割至关重要,并且在 HCV 核糖核酸 (RNA) 复制过程中起关键作用。 NS4A 是 NS3 的激活因子。 HCV 是属于黄病毒科的一种小的、有包膜的单链 RNA 病毒,感染与肝细胞癌 (HCC) 的发展有关。 | |||
T12962 |
Sofosbuvir impurity G
|
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Sofosbuvir impurity G 是 Sofosbuvir 的非对映异构体,是 Sofosbuvir 的杂质。其中 Sofosbuvir 能够抑制 HCVRNA 的复制,具有抗丙型肝炎病毒作用。 | |||
T4121 |
Bicyclol
SY801,双环醇 |
HBV; Autophagy | Autophagy; Microbiology/Virology |
Bicyclol (SY801) 是一种抗肝炎 HBV 和 HCV 药物。 | |||
T19675 |
SM360320
CL-087,SM 360320,CL 087,1V136,SM-360320,CL087 |
TLR | Immunology/Inflammation |
SM360320 (CL-087) 是一种有效的特异性 TLR7 激动剂。 SM360320 除了其 IFN 介导的活性外,还通过 I 型 IFN 非依赖性机制抑制肝细胞中的 HCV 复制。 SM360320 可用于研究作为治疗性 DNA 疫苗的免疫佐剂。 | |||
T60531 |
2'-C-Methyladenosine
|
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
2'-C-Methyladenosine 是丙型肝炎病毒(HCV)复制的抑制剂,分离自肾棒状杆菌。2'-C-Methyladenosine 抑制 HCV 复制子和 NS5B 催化的 RNA 合成,IC50值分别为 0.3 μM 和 1.9 μM。2'-C-Methyladenosine 还对Leishmania guyanensis (Lgy)和Leishmania braziliensis中的 LRV1有抑制作用。 | |||
T73253 |
EIDD-2749
4'-Fluorouridine,4'-FlU ; 4'-Fluorouridine,4'-FlU |
||
EIDD-2749 (4'-Fluorouridine) 是一种口服有效的RdRp 抑制剂。EIDD-2749 能有效抑制RSV 和SARS-CoV-2的复制。EIDD-2749 还表现出抗HCV 和淋巴细胞性脉络丛脑膜炎病毒 (LCMV) 的活性。EIDD-2749 是一种很有潜力的COVID-19口服治疗候选剂,也适用于其他 RNA 病毒的研究。 | |||
T16774 | RO-9187 | HCV Protease | Microbiology/Virology; Proteases/Proteasome |
RO-9187 is an effective HCV virus replication inhibitor(IC50: 171 nM). | |||
T19486 | Nucleoside-Analog-2 | Others | Others |
Nucleoside-Analog-2 is a 4'-Azidocytidine analogue, used to against Hepatitis C virus (HCV) replication. | |||
T14289 |
Anguizole
|
Others | Others |
Anguizole, a small molecule, effectively inhibits Hepatitis C Virus (HCV) replication by modifying the subcellular distribution of NS4B. It demonstrates its potency with an IC50 value, highlighting its specific target action against HCV. | |||
T27732 |
KIN1400
|
||
KIN1400, a novel IRF3 activator, triggers IRF3-dependent innate immune antiviral genes and IFNbeta307 expression, suppresses WNV, DV infection, and HCV replication. | |||
T14095 |
ACH-806
GS9132 |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
ACH-806 is an NS4A antagonist. It can inhibit Hepatitis C Virus (HCV) replication with an EC50 of 14 nM. | |||
T12969 |
Sofosbuvir impurity N
|
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Sofosbuvir impurity N is an diastereoisomer of Sofosbuvir.Sofosbuvir is an HCV RNA replication inhibitor, with potent anti-hepatitis C virus activity. | |||
T12965 |
Sofosbuvir impurity J
|
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Sofosbuvir impurity J is an diastereoisomer of Sofosbuvir.Sofosbuvir is an HCV RNA replication inhibitor, with potent anti-hepatitis C virus activity. | |||
T12964 |
Sofosbuvir impurity I
|
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Sofosbuvir impurity I is an diastereoisomer of Sofosbuvir.Sofosbuvir is an HCV RNA replication inhibitor, with potent anti-hepatitis C virus activity. | |||
T71006 |
BI-1388
|
||
BI-1388 is a highly potent inhibitor of HCV NS3 protease activity, inhibiting viral replication for various HCV genotypes and for resistant mutants D168V and R155K. | |||
T12966 | Sofosbuvir impurity K | HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Sofosbuvir impurity K is an diastereoisomer of Sofosbuvir.Sofosbuvir is an HCV RNA replication inhibitor, with potent anti-hepatitis C virus activity. | |||
T12957 |
Sofosbuvir impurity B
|
Others | Others |
Sofosbuvir impurity B is the less active impurity of Sofosbuvir. Sofosbuvir is an active HCV RNA replication inhibitor in the HCV replicon assay, with potent anti-hepatitis C virus (HCV) activity. | |||
T12960 |
Sofosbuvir impurity E
|
Others | Others |
Sofosbuvir impurity E is the less active impurity of Sofosbuvir. Sofosbuvir is an active HCV RNA replication inhibitor in the HCV replicon assay,with potent anti-hepatitis C virus (HCV) activity. | |||
T79625 | HCV-IN-43 | ||
HCV-IN-43(化合物2)为HCVNS5B蛋白抑制剂,有效抑制丙型肝炎病毒(HCV)复制,适用于HCV感染研究。 | |||
T79626 | HCV-IN-44 | ||
HCV-IN-44(化合物28)为一种针对HCVNS5B蛋白的抑制剂,能够有效阻止丙型肝炎病毒(HCV)的复制。此化合物主要应用于HCV感染的相关研究。 | |||
T12968 |
Sofosbuvir impurity M
|
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Sofosbuvir impurity M is an diastereoisomer of Sofosbuvir.Sofosbuvir is an HCV RNA replication inhibitor, with potent anti-hepatitis C virus activity. | |||
T12955 |
Sofosbuvir D6
PSI-7977 D6,GS-7977 D6 |
Others | Others |
Sofosbuvir D6 is the deuterium labeled Sofosbuvir. Sofosbuvir is an active inhibitor of HCV RNA replication in the HCV replicon assay, demonstrates potent anti-hepatitis C virus (HCV) activity. | |||
T70760 |
NVP018
|
||
NVP018, also known as BC 556, is a potent inhibitor of hepatitis B virus, hepatitis C virus (HCV), and HIV-1 replication, shows minimal inhibition of major drug transporters, and has a high barrier to generation of both HCV and HIV-1 resistance.. | |||
T12959 |
Sofosbuvir impurity D
|
Others | Others |
Sofosbuvir impurity D is the less active impurity of Sofosbuvir. Sofosbuvir is an active HCV RNA replication inhibitor in the HCV replicon assay,with potent anti-hepatitis C virus (HCV) activity. | |||
T81694 |
NCI-B16
|
||
NCI-B16为小分子RNA结合剂,具有抑制HCV病毒复制的功能。 | |||
T16715 |
Furaprofen
呋喃洛芬,R803 |
Others | Others |
Furaprofen is substantially more potent against genotype 1a and 1b replicons (EC50, ~30 nM) than against the genotype 2a replicon (EC50:1000 nM). Furaprofen is an effective HCV replication inhibitor. | |||
T12954 |
Sofosbuvir 13CD3
GS-7977 13CD3,PSI-7977 13CD3 |
Others | Others |
Sofosbuvir 13CD3 is the deuterium labeled Sofosbuvir. Sofosbuvir is an active HCV RNA replication inhibitor in the HCV replicon assay, with potent anti-hepatitis C virus (HCV) activity. | |||
T12958 | Sofosbuvir impurity C | Others | Others |
Sofosbuvir impurity C is the less active impurity of Sofosbuvir. Sofosbuvir is an active HCV RNA replication inhibitor in the HCV replicon assay,with potent anti-hepatitis C virus (HCV) activity. | |||
T39347 | RG-101 | ||
RG-101 is a hepatocyte-targeted N-acetylgalactosamine conjugated oligonucleotide that functions as an antagonist for miR-122, an essential host factor in the replication of the hepatitis C virus (HCV). | |||
T33432 |
MK-3281
MK 3281,MK3281 |
||
MK-3281 is a potent, orally bioavailable hepatitis C virus NS5B polymerase finger-loop inhibitor. It is also an inhibitor of attractive molecular properties with good potency in HCV subgenomic replication trials and suitable for clinical candidates. | |||
T71085 |
BMS-824
|
||
BMS-824 is a potent NS5A inhibitor. The 50% inhibition of HCV replicon replication for BMS-824 was approximately 5 nM, with a therapeutic index of >10,000. BMS-824 showed good specificity for HCV, as it was not active against several other RNA and DNA viruses. | |||
T12967 |
Sofosbuvir impurity L
|
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Sofosbuvir impurity L is an diastereoisomer of Sofosbuvir.Sofosbuvir is an HCV RNA replication inhibitor, with potent anti-hepatitis C virus activity. | |||
T69935 |
L0909
|
||
L0909 is an orally available inhibitors of Hepatitis C virus with a novel mechanism of action (EC50 = 0.022 μM, SI > 600). L0909 could block HCV replication by acting on the HCV entry stage. The high sensitivity to clinical resistant HCV mutants and synergistic effect with clinical drugs were observed for this compound. L0909 as a promising HCV entry inhibitor for single or combinational therapeutic potential. | |||
T12963 |
Sofosbuvir impurity H
|
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Sofosbuvir impurity H, an diastereoisomer of Sofosbuvir, is the impurity of Sofosbuvir. Sofosbuvir (PSI-7977) is a diastereoisomer of Sofosbuvir.Sofosbuvir is an HCV RNA replication inhibitor, with potent anti-hepatitis C virus activity. | |||
T74625 |
HCV-IN-41
|
||
HCV-IN-41 (compound 4) 是一种高效的丙肝病毒 (HCV)抑制剂,对 HCV1b、2a、3a 和 4a 的 EC50分别为 0.006762 nM、5.183 nM、1.365 nM 和 142.2 nM。HCV-IN-41 能降低 HCVRNA 的复制。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T7607 |
PSI-6130
R 1656,2'-去氧-2'-氟-2'-C-甲基胞苷 |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
PSI-6130 (R 1656) 是高效选择性 HCV NS5B 聚合酶抑制剂,抑制 HCV 复制,IC50值为 0.6 μM。 | |||
TN3809 | Dehydrojuncusol | HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Dehydrojuncusol, a new inhibitor of hepatitis C virus RNA replication, it inhibits infection of different HCV genotypes by targeting the NS5A protein and is active against resistant HCV variants frequently found in patients with treatment failure. |